Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Examination for mucin in synovial fluid |
Has measured component (attribute) |
False |
Mucin |
Inferred relationship |
Some |
|
Examination for mucin in synovial fluid |
Component |
False |
Mucin |
Inferred relationship |
Some |
|
Gastric mucin 3.5% (porcine) spray |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mucin |
Inferred relationship |
Some |
|
Mucin 63 mg and xylitol 39 mg oromucosal lozenge |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mucin |
Inferred relationship |
Some |
|
Cancer antigen 15-3 |
Is a |
True |
Mucin |
Inferred relationship |
Some |
|
Product containing mucin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mucin |
Inferred relationship |
Some |
1 |
Product containing mucin and xylitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mucin |
Inferred relationship |
Some |
1 |
Mucin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mucin |
Inferred relationship |
Some |
1 |
Product containing only mucin and xylitol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mucin |
Inferred relationship |
Some |
1 |
Product containing precisely mucin 35 milligram/1 milliliter conventional release oral spray (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Mucin |
Inferred relationship |
Some |
1 |
Product containing precisely mucin 35 milligram/1 milliliter conventional release oral spray (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Mucin |
Inferred relationship |
Some |
1 |
Product containing mucin and xylitol in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mucin |
Inferred relationship |
Some |
1 |
Mucin 63 mg and xylitol 39 mg oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mucin |
Inferred relationship |
Some |
1 |
Mucin 63 mg and xylitol 39 mg oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mucin |
Inferred relationship |
Some |
1 |
Product containing only mucin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mucin |
Inferred relationship |
Some |
1 |
Product containing mucin in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Mucin |
Inferred relationship |
Some |
1 |
Product containing only mucin and xylitol in oromucosal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mucin |
Inferred relationship |
Some |
1 |
Mucin-containing product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mucin |
Inferred relationship |
Some |
1 |
Mucin only product in oromucosal dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Mucin |
Inferred relationship |
Some |
1 |
Mucin 35 mg/mL oromucosal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Mucin |
Inferred relationship |
Some |
1 |
Mucin 35 mg/mL oromucosal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Mucin |
Inferred relationship |
Some |
1 |